Business in Brief: Tel Aviv Shares Sharply Lower as China Sets Off Global Selloff

Zim delaying IPO planned for first half; Teva, Active Biotech halt higher doses of oral multiple sclerosis drug in trials; Frutarom buys half of algae-tech startup.

comments Print
Tel Aviv shares sharply lower as China sets off global selloff